Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
- Type
- Retraction
- Notice date
- 11/2/2021 0:00
- Journal
- Oncology Reports
- Publisher
- Spandidos
- Notice DOI
- 10.3892/or.2021.8213
- Original paper DOI
- 10.3892/or.2014.3698